It’s the season of IPOs in China. After it was reported on Monday that Tencent Music is planning an IPO, now it’s the turn of ride-hailing firm Didi Chuxing to join the gang. Didi Chuxing is said to be in negotiations for an IPO that will value it at $70 billion to $80 billion. Last December, Didi reached a valuation of $50 billion after receiving financing of $4 billion from investors.
It is speculated that the IPO could take place in the second half of 2018, but there has been no confirmation on this. Didi Chuxing provided no comment on the matter.
Didi Chuxing also announced its expansion into Mexico, an Uber-dominant market. It debuted its service in Toluca on Monday and is looking to expand into other major Mexican cities over the coming months. Didi also has plans to launch services in Taiwan.
With its move into Mexico, Didi is taking Uber head-on. Recall that Didi bought Uber’s Chinese operations in 2016 and also acquired a minority stake in Uber. Through that deal, Uber became Didi’s biggest stakeholder, and this makes for an interesting situation as Didi pushes into Uber’s core markets like Mexico and Brazil. Didi purchased Brazilian ride-hailing company 99 earlier this year.
It is speculated that the IPO could take place in the second half of 2018
Didi has partnered with several cab service providers including Lyft as part of its growth and expansion efforts. Didi is also looking into the idea of developing its own fleet of Didi cars by teaming up with traditional automotive companies.
As the automotive market sees a transformation with the advent of electric and autonomous vehicles and as ride-hailing and ride-sharing services gain prominence, there is a need for carmakers and cab providers to evolve accordingly and bring forth smart mobility solutions. Didi is looking at partnerships with automakers to be a part of this trend and to make advancements in this area. Didi has some grand plans for the future, and it will be interesting to see how they unfold.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
